BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32258408)

  • 1. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles.
    Zhuang J; Gong H; Zhou J; Zhang Q; Gao W; Fang RH; Zhang L
    Sci Adv; 2020 Mar; 6(13):eaaz6108. PubMed ID: 32258408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced lysosomal escape of cell penetrating peptide-functionalized metal-organic frameworks for co-delivery of survivin siRNA and oridonin.
    Cai M; Yao Y; Yin D; Zhu R; Fu T; Kong J; Wang K; Liu J; Yao A; Ruan Y; Shi W; Zhu Q; Ni J; Yin X
    J Colloid Interface Sci; 2023 Sep; 646():370-380. PubMed ID: 37207419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment.
    Tao T; Rehman SU; Xu S; Zhang J; Xia H; Guo Z; Li Z; Ma K; Wang J
    J Mater Chem B; 2024 May; 12(17):4080-4096. PubMed ID: 38577851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
    Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
    J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
    Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
    J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism.
    Zhang J; Han M; Zhang J; Abdalla M; Sun P; Yang Z; Zhang C; Liu Y; Chen C; Jiang X
    Int J Pharm; 2023 Jun; 640():123025. PubMed ID: 37164186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging.
    Yu Q; Liu Y; Cao C; Le F; Qin X; Sun D; Liu J
    Nanoscale; 2014 Aug; 6(15):9279-92. PubMed ID: 24986368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional siRNA-Laden Hybrid Nanoplatform for Noninvasive PA/IR Dual-Modal Imaging-Guided Enhanced Photogenetherapy.
    Feng J; Yu W; Xu Z; Hu J; Liu J; Wang F
    ACS Appl Mater Interfaces; 2020 May; 12(20):22613-22623. PubMed ID: 32338491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.
    Liu Y; He M; Yuan Y; Nie C; Wei K; Zhang T; Chen T; Chu X
    ACS Nano; 2023 Apr; 17(8):7721-7732. PubMed ID: 37023215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
    Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Pyruvate Kinase M2
    Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
    ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of siRNA payloads to target KRAS-mutant cancer.
    Yuan TL; Fellmann C; Lee CS; Ritchie CD; Thapar V; Lee LC; Hsu DJ; Grace D; Carver JO; Zuber J; Luo J; McCormick F; Lowe SW
    Cancer Discov; 2014 Oct; 4(10):1182-1197. PubMed ID: 25100204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane Cholesterol Depletion Enhances Enzymatic Activity of Cell-Membrane-Coated Metal-Organic-Framework Nanoparticles.
    Wang S; Kai M; Duan Y; Zhou Z; Fang RH; Gao W; Zhang L
    Angew Chem Int Ed Engl; 2022 Jun; 61(24):e202203115. PubMed ID: 35395111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Wang K; Kievit FM; Sham JG; Jeon M; Stephen ZR; Bakthavatsalam A; Park JO; Zhang M
    Small; 2016 Jan; 12(4):477-87. PubMed ID: 26641029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.